DaVita Inc. provides kidney dialysis services through a network of 2,816 outpatient dialysis centers in the United States, serving 204,200 patients, and 321 outpatient dialysis centers in 10 other countries serving 3,200 patients. The company primarily treats end-stage renal disease, which requires patients to undergo dialysis 3 times per week for the rest of their lives unless they receive a donor kidney. The company has a 37% market share in the U.S. dialysis market. It is organized in Delaware and based in Denver.
In 2020, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2020, 90% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2020, generate all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs.
The company is ranked 230th on the Fortune 500.
The name "DaVita" is derived from the Italian language phrase "Dare Vita", which means "giving life".
Highest paying job titles at Davita include Quality Assurance Engineer, Director, Corporate Counsel, and Director, Strategy